Methacrylic Acid

Methacrylic Acid

SCHEMBL28437643

C=C(C)C(=O)O.C=C(C)C(=O)O.C=C(C)C(=O)O.C=C(C)C(=O)O.C=CC.C=CC.OCC(O)CO

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
TGFBR1 P36897 1/20 0.38
TET2 Q6N021 4/20 0.33
OR51E2 Q9H255 1/20 0.32
TET3 O43151 1/20 0.31
TET1 Q8NFU7 1/20 0.31
ALOX15 P16050 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL27992510 1.00 ALDH1A1 (0.39) ALDH1A1LMNATGFBR1TET2OR51E2
Methacrylic Acid SCHEMBL27605057 0.98 ALDH1A1 (0.38) ALDH1A1LMNATGFBR1TET2OR51E2
Methacrylic Acid SCHEMBL31053467 0.91 LMNA (0.47) ALDH1A1LMNATGFBR1TET2OR51E2
Methacrylic Acid SCHEMBL5710041 0.91 LMNA (0.47) ALDH1A1LMNATGFBR1TET2OR51E2
Methacrylic Acid SCHEMBL29833500 0.91 LMNA (0.47) ALDH1A1LMNATGFBR1TET2OR51E2
Methacrylic Acid SCHEMBL35386 0.91 LMNA (0.47) ALDH1A1LMNATGFBR1TET2OR51E2
Methacrylic Acid SCHEMBL11414820 0.91 LMNA (0.47) ALDH1A1LMNATGFBR1TET2OR51E2
Methacrylic Acid SCHEMBL35508 0.91 LMNA (0.47) ALDH1A1LMNATGFBR1TET2OR51E2
Methacrylic Acid SCHEMBL15733068 0.91 LMNA (0.47) ALDH1A1LMNATGFBR1TET2OR51E2
Methacrylic Acid SCHEMBL108430 0.91 LMNA (0.47) ALDH1A1LMNATGFBR1TET2OR51E2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107148411-B Phenylhydrazine/anhydride adducts and anaerobically curable compositions using phenylhydrazine/anhydride adducts 汉高知识产权控股有限责任公司 2020-06-19 CN disclosed